Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

  • Business News
  • June 18, 2026, 20:57 UTC
  • 1
  • 1 comments

Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

Market reaction Comment Full text

ODYSIGHT.AI INC. (ODYS)

  • Business News
  • June 18, 2026, 20:52 UTC
  • 1
  • 1 comments

Other Report or Announcement

Market reaction Comment Full text

SCAGE FUTURE (SCAG)

  • Business News
  • June 18, 2026, 20:45 UTC
  • 5
  • 1 comments

Scage Future Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Market reaction Comment Full text

CONTANGO ORE, INC. (CTGO)

  • Business News
  • June 18, 2026, 20:45 UTC
  • 3
  • 1 comments

Contango Announces Results of the 2026 Virtual Annual Meeting of Stockholders

Market reaction Comment Full text

COMSTOCK HOLDING COMPANIES, INC. (CHCI)

  • Business News
  • June 18, 2026, 20:45 UTC
  • 6
  • 1 comments

Comstock Appoints former Blackstone and Citigroup Leader David Hirsh to Board of Directors

Market reaction Comment Full text

BTQ TECHNOLOGIES CORP. (BTQ)

  • Business News
  • June 18, 2026, 20:42 UTC
  • 6
  • 1 comments

BTQ TECHNOLOGIES ANNOUNCES AT-THE-MARKET EQUITY PROGRAM

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • June 18, 2026, 20:40 UTC
  • 5
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • June 18, 2026, 20:40 UTC
  • 5
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

CENTRUS ENERGY CORP (LEU)

  • Business News
  • June 18, 2026, 20:38 UTC
  • 6
  • 1 comments

Centrus Energy Corp. Announces Extension of Section 382 Rights Agreement

Market reaction Comment Full text

UNIFIRST CORP (UNF)

  • Business News
  • June 18, 2026, 20:36 UTC
  • 5
  • 1 comments

UniFirst Corporation Plans to Announce Third Quarter Results on July 1, 2026

Market reaction Comment Full text
  • Previous
  • 2731
  • 2732
  • 2733
  • 2734
  • 2735
  • Next

Search

News categories

  • Technical Exchange News(14216)
  • Event(6229)
  • SEC News(365267)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(224317)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin